Affimed

YTD

ALL

Why Robinhood?

You can watch Affimed and buy or sell other stocks, ETFs, and their options commission-free!

About AFMD

Affimed NV is a clinical-stage immuno-oncology company, which engages in the discovery and development of cancer immunotherapies. The company’s proprietary ROCK platform enables a tumor-targeted approach to recognize and kill a range of hematologic and solid tumors, enabling a broad pipeline of wholly-owned and partnered single agent and combination therapy programs.

CEO

Shawn M. Leland, PharmD

CEOShawn M. Leland, PharmD

Employees

—

Employees—

Headquarters

Mannheim, Baden Wuerttemberg

HeadquartersMannheim, Baden Wuerttemberg

Founded

2000

Founded2000

Employees

—

Employees—

AFMD Key Statistics

Market cap

1.50K

Market cap1.50K

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

3.29K

Average volume3.29K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$1.13

52 Week high$1.13

52 Week low

—

52 Week low—

Stock Snapshot

As of today, Affimed(AFMD) shares are valued at $5.91. The company's market cap stands at 1.5K.

Affimed(AFMD) stock opened on 2026-02-07 at —. The price climbed to — and dipped to —.

The Affimed(AFMD)'s current trading volume is 0, compared to an average daily volume of 3.29K.

People also own

Based on the portfolios of people who own AFMD. This list is generated using Robinhood data, and it’s not a recommendation.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.